Natalizumab affects the T-cell receptor repertoire in patients with multiple sclerosis. Warnke C, Mausberg AK, Stettner M, Dehmel T, Nekrich L, Meyer Zu Horste G, Hartung H-P, Fogdell-Hahn A, Adams O, Kieseier BC Neurology. 2013 Sep 18. PMID: 24049136. Abstract CommentRecommendBookmarkWatch